Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
50972-17-3CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)CPFOLLRNADZZWEX-FFGRCDKISA-NBacampicillin is a penicillanic acid ester that is the 1-ethoxycarbonyloxyethyl ester of ampicillin. It is a semi-synthetic, microbiologically inactive prodrug of ampicillin. It has a role as a prodrug. It is functionally related to an ampicillin.
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
Bacampicillin
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
J - Antiinfectives for systemic use
QJ - Antiinfectives for systemic use
During absorption from the gastrointestinal tract, bacampicillin is hydrolyzed by esterases present in the intestinal wall. It is microbiologically active as ampicillin, and exerts a bactericidal action through the inhibition of the biosynthesis of cell wall mucopeptides.
DefinitionChEBI: A penicillanic acid ester that is the 1-ethoxycarbonyloxyethyl ester of ampicillin. It is a semi-synthetic, microbiologically inactive prodrug of ampicillin.
50972-17-3DTXSID2048030CHEMBL1583CHEBI:2968